Biological and clinical significance of epigenetic silencing of MARVELD1 gene in lung cancer

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Shi, Ming ^a   Wang, Shan ^a   Yao, Yuanfei ^a   Li, Yiqun ^a   Zhang, Hao ^a   Han, Fang ^a   Nie, Huan ^a   Su, Jie ^a   Wang, Zeyu ^a   Yue, Lei ^a   Cao, Jingyan ^b   Li, Yu ^a  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; MARVELD1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; STOP CODON; TUMOR MARKER;

DNA METHYLATION; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; HUMAN; LUNG TUMOR; NONSENSE MEDIATED MRNA DECAY; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; STOP CODON; TUMOR CELL LINE;

BIOMARKERS, TUMOR; CELL LINE, TUMOR; CODON, NONSENSE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE SILENCING; HISTONES; HUMANS; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NONSENSE MEDIATED MRNA DECAY; SIGNAL TRANSDUCTION;

EID: 84947926947     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07545     Document Type: Article

References (28)

1. Floquet, C., Deforges, J., Rousset, J. P. & Bidou, L. Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides. Nucl. Acids Res. 39, 3350-3362 (2011).
2. Chan, T. A. et al. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med. 5, e114 (2008).
3. Potapova, A., Hoffman, A. M., Godwin, A. K., Al-Saleem, T. & Cairns, P. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Cancer Res. 68, 998-1002 (2008).
4. Maquat, L. E. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nature reviews. Mol. Cell Biol. 5, 89-99 (2004).
5. Pastor, F., Kolonias, D., Giangrande, P. H. & Gilboa, E. Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature 465, 227-230 (2010).
6. Wang, D., Wengrod, J. & Gardner, L. B. Overexpression of the c-myc oncogene inhibits nonsense-mediated RNA decay in B lymphocytes. J. Biol. Chem. 286, 40038-40043 (2011).
7. Heng, H. H. et al. Genetic and epigenetic heterogeneity in cancer: a genomecentric perspective. J. Cell. Physiol. 220, 538-547 (2009).
8. Bhalla, A. D. et al. Nonsense codons trigger an RNA partitioning shift. J. Biol. Chem. 284, 4062-4072 (2009).
9. Resta, N. et al. Ahomozygous frameshiftmutation in the ESCO2 gene: evidence of intertissue and interindividual variation in Nmd efficiency. J. Cell. Physiol. 209, 67-73 (2006).
10. Kervestin, S. & Jacobson, A. NMD: a multifaceted response to premature translational termination. Nature reviews. Mol. Cell Biol. 13, 700-712 (2012).
11. Egecioglu, D. E. & Chanfreau, G. Proofreading and spellchecking: a two-tier strategy for pre-mRNA splicing quality control. RNA 17, 383-389 (2011).
12. Chang, Y. F., Chan, W. K., Imam, J. S. & Wilkinson, M. F. Alternatively spliced Tcell receptor transcripts are up-regulated in response to disruption of either splicing elements or reading frame. J. Biol. Chem. 282, 29738-29747 (2007).
13. Wong, J. J. et al. Orchestrated intron retention regulates normal granulocyte differentiation. Cell 154, 583-595 (2013).
14. Lasalde, C. et al. Identification and functional analysis of novel phosphorylation sites in the RNA surveillance protein Upf1. Nucl. Acids Res. 42, 1916-1929 (2014).
15. Lloyd, J. P. & Davies, B. SMG1 is an ancient nonsense-mediated mRNA decay effector. Plant J. 76, 800-810 (2013).
16. Mendell, J. T., ap Rhys, C. M. & Dietz, H. C. Separable roles for rent1/hUpf1 in altered splicing and decay of nonsense transcripts. Science 298, 419-422 (2002).
17. Brumbaugh, K. M. et al. The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells. Mol. Cell 14, 585-598 (2004).
18. Wang, S. et al. Identification and characterization of MARVELD1, a novel nuclear protein that is down-regulated in multiple cancers and silenced by DNA methylation. Cancer Lett. 282, 77-86 (2009).
19. Yu, Y. et al. MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma. Cancer Sci. 103, 716-722 (2012).
20. Wang, S. et al. MARVELD1 regulates integrin beta1-mediated cell adhesion and actin organization via inhibiting its pre-mRNA processing. Int. J. Biochem. Cell Biol. 45, 2679-2687 (2013).
21. Dias, S. M., Wilson, K. F., Rojas, K. S., Ambrosio, A. L. & Cerione, R. A. The molecular basis for the regulation of the cap-binding complex by the importins. Nature Struct. Mol. Biol. 16, 930-937 (2009).
22. Sato, H. & Maquat, L. E. Remodeling of the pioneer translation initiation complex involves translation and the karyopherin importin beta. Genes Dev. 23, 2537-2550 (2009).
23. Cadieux, B., Ching, T. T., Vanden Berg, S. R. & Costello, J. F. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res. 66, 8469-8476 (2006).
24. Pfeifer, G. P. & Rauch, T. A. DNA methylation patterns in lung carcinomas. Sem. Cancer Biol. 19, 181-187 (2009).
25. Vogiatzi, P., Vindigni, C., Roviello, F., Renieri, A. & Giordano, A. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J. Cell. Physiol. 211, 287-295 (2007).
26. Hu, J., Li, Y. & Li, P. MARVELD1 Inhibits Nonsense-Mediated RNA Decay by Repressing Serine Phosphorylation of UPF1. PloS one 8, e68291 (2013).
27. Shi, M., Yao, Y., Han, F. & Li, Y. MAP1S Controls Breast Cancer Cell TLR5 Signaling Pathway and Promotes TLR5 Signaling-based Tumor Suppression. PloS one 9, e86839 (2014).
28. Sun, B. K., Deaton, A. M. & Lee, J. T. A transient heterochromatic state in Xist preempts X inactivation choice without RNA stabilization. Mol. Cell 21, 617-628 (2006).